Zofran
information and resources from the National Cancer Institute
Zofran
(Other name for: ondansetron)Zoladex
(Other name for: goserelin)Zofran
(Other name for: ondansetron)
|
|
|
|
news articles
American Pharma Gets Tentative Zofran OK Mar 9, 2006
MSN Money ...the Food and Drug Administration granted tentative approvals for the specialty drug company's generic versions of GlaxoSmithKline PLC's nausea treatment Zofran ...
Hana's Potential Takeover Price Seen Near $20 Mar 30, 2006
Forbes ...year. Zensana is the spray form of leading anti-nausea drug Zofran, marketed by GlaxoSmithKline (nyse: GSK - news - people ). "We ...
Boy Dies After Swallowing Lead-Filled Charm Mar 31, 2006
MedPage Today, Doctors there diagnosed probable viral gastroenteritis and administered Zofran (ondansetron) and sent home with instructions to parents to monitor fluid intake ...
NovaDel Announces That Ondansetron Oral Spray Has Met The Key ... Mar 9, 2006
Business Wire (press release), ...-- Pivotal pharmacokinetic study confirms that ondansetron 8 mg oral spray is statistically bioequivalent to 8 mg ondansetron (Zofran(R)) tablet, meeting the ...
Fight to Survive ; Patients Who Must Renegotiate Drug Benefits ... Mar 11, 2006
International News Service, That means the 61-year-old former nurse will receive 90 more Zofran pills to combat the chronic nausea she suffers as a result of a 12-year battle against AIDS ...
-- Hana targets US commercial launch of ondansetron oral spray in Mar 9, 2006
PharmaLive.com (press release), The studies established bioequivalence of Zensana(TM)to the Zofran(R) tablet, evaluated the pharmacokinetic profile of Zensana(TM) after administration of ...
Hana Biosciences Successfully Completes Pivotal Trials of Zensana ... Mar 9, 2006
Business Wire (press release), ...confirm Zensana(TM) (ondansetron oral spray) 8 mg dose is statistically bioequivalent to the current commercially available 8 mg ondansetron (Zofran(R)) tablet ...
MGI Pharma "neutral," target price reduced Mar 10, 2006
newratings.com ...note published yesterday, the analysts mention that American Pharmaceutical Partners (APPX) has received a tentative approval for generic Zofran from the FDA. ...
Hana Paying Up To $42M For Inex’s Cancer Drugs Mar 17, 2006
BioWorld Online (subscription), ...confirmed 5HT3 inhibitor at the 8-mg dose is statistically bioequivalent to the current commercially available 8-mg ondansetron (GSK’s Zofran, which went ...
American Pharma Partners Granted 2 Tentative FDA Approvals For ... Mar 9, 2006
Trading Markets, ...multiple-dose vials. Ondansetron Injection is the generic equivalent of GlaxoSmithKline's Zofran Injection. Ondansetron Injection ...
American Pharmaceutical drug gets FDA approval Mar 9, 2006
Crain's Chicago Business, Partners Inc. on Thursday said US regulators tentatively approved its generic versions of GlaxoSmithKline Plc's Zofran injection. The ...
Uncle Sam vets the names of potential drugs Mar 17, 2006
Pittsburgh Post Gazette, The other drugs were Zofran, an antinausea drug, and Zosyn, an antibiotic. Bob Lee, trademark counsel at Lilly, says he was surprised by the FDA's rejection. ...
Dropping GSK for AZ is a bold move but the time is right to make ... Mar 17, 2006
Times Online, Flonase, a hayfever treatment, and further court battles will determine the commercial prognosis for Wellbutrin XL, an anti-depressant, and for Zofran, used to ...
American Pharmaceutical Partners Receives Two Tentative FDA ... Mar 9, 2006
PR Newswire (press release), Drug Applications (ANDAs) for Ondansetron Injection, USP, single-dose and multiple-dose vials, the generic equivalent of GlaxoSmithKline's Zofran(R) Injection. ...
Many drug names fail to pass FDA muster Mar 19, 2006
Sun-Sentinel.com, ...others used in critical care. The other drugs were Zofran, an antinausea drug, and Zosyn, an antibiotic. Bob Lee, trademark counsel ...
Hay fever ruling puts $900m of GSK revenues at risk Mar 7, 2006
Independent, ...than they had hoped, but it wasn't far from their central planning." Mr Garnier said last month that Wellbutrin, an antidepressant, and Zofran, a treatment to ...
Judge denies Glaxo, allows generic Flonase Mar 7, 2006
Raleigh Triangle Business Journal, ...its financial guidance for 2006 to 10 percent growth due in part to the likelihood of generic competition to Flonase and nausea drug Zofran reaching the market ...
American Pharmaceutical Partners Receives 2 Tentative FDA ... Mar 9, 2006
Trading Markets, New Drug Applications for Ondansetron Injection, USP, single-dose and multiple-dose vials, the generic equivalent of GlaxoSmithKline's Zofran Injection. ...
Nausea plagues reader ASKDR.GOTT Peter Gott, MD Mar 10, 2006
Monterey County Herald, ...answers. I know you cannot answer all of your letters, but I am tired of getting nauseated and taking Zofran to relieve the symptoms. ...
NovaDel Reports Second Fiscal Quarter Results Mar 16, 2006
Genetic Engineering News, The studies demonstrated Zensana(TM) 8mg dose is statistically bioequivalent to the current commercially available 8mg tablet (Zofran(R)). It is anticipated ...
Hana Biosciences Reports 2005 Results from Operations Mar 16, 2006
Genetic Engineering News, ...which demonstrated that an 8 mg dose of Zensana(TM) oral spray is statistically bioequivalent to the commercially available 8 mg ondansetron (Zofran(R)) tablet ...
Dr Reddy's: betapharm push Mar 9, 2006
Business Standard, ...downgrades. The forecasts do not include authorised generic upside from Zocor, Zofran 180-day exclusivity or R&D-related benefits. ...
NovaDel Pharma Q2 Net Loss Widens On Higher Expenses; Reveals ... Mar 16, 2006
Trading Markets, ...positive study results of clinical trials for Zensana Ondansetron Oral Spray, demonstrating Zensana 8mg dose to be statistically bioequivalent to Zofran 8 mg ...
[ Local Focus ] Mar 10, 2006
International News Service, ...received two tentative approvals from the US Food and Drug Administration for Ondansetron Injection, the company's generic version of GlaxoSmithKline's Zofran. ...
Blockbuster Drugs' Market Share in Danger 21 Dec 2005
PR Newswire (press release), ...by 2008. This year alone at least eight blockbusters, including Allegra, Plavix and Zofran, have had patents expire. These drugs ...
Par Unit Gets FDA OK for Generic Zofran Nov 21, 2005
MSN Money Drug Administration gave the drug maker's Kali Laboratories unit final approval to market a generic version of GlaxoSmithKline PLC's nausea treatment Zofran ODT ...
GlaxoSmithKline: Zofran sales set for off-Par performance Nov 22, 2005
Pharmaceutical Business Review 22 Nov 2005, 17:58 GMT - The FDA has granted Par Pharmaceuticals approval to market a generic version of GlaxoSmithKline's anti-emetic Zofran, with 180 days of ...
FDA approves Par's generic Zofran Nov 21, 2005
United Press International WASHINGTON, Nov. 21 (UPI) -- Par Pharmaceuticals said Monday it has been approved to market a generic version of GlaxoSmithKline's Zofran. ...
First-Time Generic Approvals: Metaglip, Zofran ODT, Floxin Otic Nov 22, 2005
Medscape (subscription) ...tablets (made by Kali Laboratories, Inc., Bedford Laboratories, Mayne Pharma USA, Inc., and Taro Pharmaceuticals USA, Inc.; brand name Zofran ODT, made by ...
FDA rescinds generic Zofran approval Nov 29, 2005
United Press International WASHINGTON, Nov. 29 (UPI) -- The Food and Drug Administration said Tuesday it has rescinded its November OK of Kali Labs' generic Zofran. ...
Hana initiates trials of oral spray Dec 14, 2005
Pharmaceutical Business Review 14 Dec 2005, 13:25 GMT - The trials will include a comparison of Hana's nasal spray with GlaxoSmithKline's Zofran which delivers the same active ingredient in ...
GlaxoSmithKline Presents Rapidly Expanding Pipeline of Oncology ... Nov 30, 2005
Finanzen.net, Casopitant - New clinical data demonstrate the potential for casopitant when combined with Zofran as a new and improved therapy for the prevention of nausea ...
Drug makers face headache as patents expire Dec 18, 2005
Austin American-Statesman (subscription), GlaxoSmithKline PLC will lose the patent protection for Zofran, its nausea drug for cancer patients that earned about $1 billion in US sales last year. ...
WestLB Lifts GlaxoSmithKline Target Price Dec 13, 2005
New Ratings ...vaccine sales from the acquisition starting in '06 (mostly Fluviral), and sales for the new products Eltrombopag starting '09 and Zofran/casopitant starting '08 ...
Par Pharmaceutical Receives Approval and Marketing Exclusivity for ... Nov 21, 2005
Yahoo! News (press release) GlaxoSmithKline currently markets ondansetron HCl ODT under the brand name Zofran ODT®. ... Annual US sales of Zofran ODT® are approximately $225 million. ...
Par Pharmaceutical Receives Approval and Marketing Exclusivity for ... Nov 21, 2005
PR Newswire (press release), GlaxoSmithKline currently markets ondansetron HCl ODT under the brand name Zofran ODT(R). The product is used for the prevention of nausea and vomiting ...
Glaxo to put 4 new cancer drugs into final trials Nov 30, 2005
Reuters ...seminar in New York. ($1.72 billion) or 5 percent of Glaxo's group sales, mostly due to anti-nausea drug Zofran. Products in clinical ...
Glaxo to put new cancer drugs into final trials Nov 30, 2005
Scotsman, Cancer currently accounts for a modest 1 billion pounds or 5 percent of Glaxo's group sales, mostly due to anti-nausea drug Zofran. ...
Glaxo to put cancer drugs into final trials Nov 30, 2005
Scotsman, Until now, cancer has been a small area for Glaxo, accounting for a modest 1 billion pounds or 5 percent of group sales, mostly due to anti-nausea drug Zofran. ...
Hana Biosciences Reports Third Quarter Results Dec 14, 2005
Genetic Engineering News, TM), the first ondansetron oral spray in chemotherapy-induced nausea and vomiting, demonstrated a bioequivalence profile comparable to oral Zofran(R) in a ...
Glaxo to showcase cancer drugs Nov 25, 2005
ABC News ...a small area for Europe's top drug maker, accounting for around 1 billion pounds or 5 percent of group sales, mostly due to anti-nausea drug Zofran, which is ...
Glaxo to display cancer drugs as new sales driver Nov 25, 2005
Daily Times, Europe’s top drug maker, accounting for around 1 billion pounds ($1.7 billion) or 5 percent of group sales, mostly due to anti-nausea drug Zofran, which is ...
Glaxo lines up new cancer drug trials Nov 30, 2005
Life Style Extra, It says Casopitant has potential, when combined with Zofran, as a new and improved therapy for the prevention of nausea and vomiting associated with ...
Glaxo makes big foray into cancer market Nov 30, 2005
United Press International The company is studying the compound casopitant in combination with its drug Zofran as a new and improved therapy to prevent nausea and vomiting associated ...
Glaxo to showcase cancer drugs as new sales driver Nov 25, 2005
Webindia123, Europe's top drug maker, accounting for around 1 billion pounds ($1.7 billion) or 5 per cent of group sales, mostly due to anti-nausea drug Zofran, which is ...
Glaxo sees 4 cancer drugs in final trials in 2006 Nov 30, 2005
Webindia123, Cancer currently accounts for a modest 1 billion pounds ($1.72 billion) or 5 per cent of Glaxo's group sales, mostly due to anti-nausea drug Zofran, which is ...
NEWS SNAP: GSK Sees 4 Drugs In Phase 3 In '06 - 2 Nov 30, 2005
Business Online, An eventual launch of casopitant could help replace sales of Zofran, a similar drug which could face generic competition from the end of 2006. ...
Burbs: Pepsi buys 'healthy' chip maker Nov 22, 2005
The Journal News.com, ...subsidiary to begin selling a generic version of GlaxoSmithKline's Zofran drug, used to treat nausea and vomiting associated with cancer treatments. ...
Hana Biosciences Initiates Pivotal Trials of Zensana(TM), First ... Dec 12, 2005
Genetic Engineering News, ...a series of pivotal pharmacokinetic trials, including comparison of Zensana(TM) to the commercially available ondansetron tablet (Zofran(R); GlaxoSmithkline). ...
PLIVA Announces Approval for Ondansetron Hydrochloride ODT Nov 21, 2005
Chemie.de (press release), GlaxoSmithKline currently markets ondansetron HCl ODT under the brand name Zofran ODT®. ... Annual US sales of Zofran ODT® are approximately USD 225m. ...
GSK to have four cancer drugs in late stage trials next year Nov 30, 2005
Forbes It also released new clinical data for casopitant, demonstrating potential when combined with its Zofran drug as a new and improved therapy for the prevention ...
Four candidates to start Phase III trials in 2006 Nov 30, 2005
MarketWatch On Casopitant, Glaxo said that new data from two Phase II dose-ranging studies showed that its use in combination with Zofran and Dexamathasone produced a ...
Glaxo Bullish on Cancer Drugs Nov 30, 2005
Red Herring, On Casopitant, clinical data showed that when combined with the nausea reducing drug Zofran and synthetic steroid dexamethasone, patients experienced ...
Pliva says ondansetron hydrochloride gets FDA approval Nov 21, 2005
Forbes ANDA) for the product. GlaxoSmithKline PLC currently markets ondansetron HCl ODT under the brand name Zofran ODT. The product is ...
DRUG SALES SLIPPING AWAY Dec 4, 2005
philly.com, GlaxoSmithKline PLC, based in London with US operations split between Philadelphia and Research Triangle Park, NC, will lose Zofran, its nausea drug for cancer ...
Burbs: O&R gas delivery rates may rise 4.7 percent Dec 1, 2005
The Journal News.com, As reported last week, the FDA granted approval for Kali's generic version of GlaxoSmithKline PLC's Zofran drug, prescribed to treat nausea and vomiting in ...
NJ business briefs Nov 22, 2005
NorthJersey.com, ...radiation therapy. GlaxoSmithKline currently markets the drug under the name Zofran, with US sales of $225 million. The release ...
Pharma Reformulates Dec 5, 2005
Chemical & Engineering News Merck's Zocor, Sanofi-Aventis' hypnotic Ambien, BMS's Pravachol (licensed from Daiichi Sankyo), Novartis' antifungal Lamisil, and GSK's nausea drug Zofran. ...
|
|
